Preview

Stamypor Case

Powerful Essays
Open Document
Open Document
2499 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Stamypor Case
Stamypor Case Study:

TABLE OF CONTENTS

Executive Summary - Situation Summary 1 Objectives 2 Central Problems 2 Recommended Actions 3 Reasoning Behind the Recommended Actions 4 Alternative Action Programs 6 Risks and Contingency Plan 7 Application of Readings 8 Works Cited 9

EXECUTIVE SUMMARY The New Business Development division of DSM is faced with the decision of whether it should continue to develop the Stamypor resin. The product is already near the end of the second stage of development. If NBD’s management board approves this product to continue into the third stage, it will require €16 million to be invested for equipment. However, if the Stamypor project is ended, no further expenditures will be required, allowing DSM-NBD to cut its losses and move on. Stamypor currently faces several problems, in addition to the large amount of money that must be invested for the project to continue. Several direct competitors already have the ability to provide similar products, while indirect competitors have the process technology to also enter this market, if they choose to do so. It is likely that Stamypor will not be able to compete without investing in a new production process. Furthermore, DSM-NBD may have difficulty finding a customer for this product. For these reasons, it is recommended that the Stamypor project should not continue. By ending this project now, no further money will be wasted on a project that probably has more potential competitors than potential customers. The Stamypor project suffered from a severe lack of analysis at several stages of its development. First, it was a poor idea to purchase a patent and try to create a need for this product. Instead, NBD should first perform research to listen to the voice of the customer, and then develop a product that the customer wants. Furthermore, the stubborn decision to ignore Stamypor’s potential competition has



Cited: (1) Rein Neiland, et al. Stamypor Case Text. Richard Ivey School of Business. University of Western Ontario. 2005. (2) Carlson, Curtis R. and Wilmot, William W. Innovation. Crown Publishing: New York. 2006. (3) Cooper, Robert G. Winning at New Products, 3rd edition. Perseus Publishing: Cambridge. 2001.

You May Also Find These Documents Helpful

  • Powerful Essays

    Direct Drugs Inc. (Direct) has created a plan for the acquisition of SolvGen Inc. (SolvGen), which is a publicly owned company. Direct has engaged an audit team to review agreement and procedures dealing with two separate material agreements. The first agreement is a research and development agreement and the second is a licensing and distribution agreement. The contract states that SolvGen entered into a five year research and development agreement with Careway Pharma Inc. on January 1, 2010. The agreement states that SolvGen will use its best efforts to develop a proprietary instrument system. They are expected to be ready for launch in the near future. SolvGen and Careway also entered in an agreement for a five year license and distribution. This agreement was entered in on January 1, 2010 as well. The terms of the research and development agreement state that SolvGen holds all intellectual rights that correspond with the research and development of the contract. Also with this agreement SolvGen is entitled to nonrefundable milestone payments from Careway and they are as follows:…

    • 1100 Words
    • 5 Pages
    Powerful Essays
  • Powerful Essays

    Prudent Solutions

    • 1251 Words
    • 6 Pages

    R&D is complete and we are now moving to commercial production of the process in house.…

    • 1251 Words
    • 6 Pages
    Powerful Essays
  • Satisfactory Essays

    Paper

    • 390 Words
    • 2 Pages

    management believes holds tremendous promise for the future. If all goes well, the company plans to patent…

    • 390 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    First, note that the $170 million spent are sunk costs, they will be lost regardless of the decision. The relevant question is whether the incremental benefits (the present value of the profits generated from the drug) exceed the incremental costs (the $30 million needed to keep the project alive). Since these costs and benefits span time, it is appropriate to compute the net present value. Here, the net present value of DAS’s R&D initiative is $26,557,759.86…

    • 6653 Words
    • 39 Pages
    Satisfactory Essays
  • Better Essays

    Summary: Minuteclinic

    • 1208 Words
    • 5 Pages

    MinuteClinic is a division of CVS Caremark Corporation, which is the largest pharmacy health care provider in the United States. MinuteClinic launched the first retail health care centers in the United States in 2000 and is the first provider to establish a national presence, with approximately 500 locations across 26 states and the District of Columbia. By creating a…

    • 1208 Words
    • 5 Pages
    Better Essays
  • Good Essays

    This is a case about Eric Peterson, who was recently hired as a product manager in charge of sales and marketing of Biometra’s catheter. This product from Biometra, a subsidiary of Scientific Materials (SciMat), was the first product ever launched by Biometra and so its success was critical for both Biometra and SciMat. From the case we see that even though Eric Peterson tries hard to meet the product target launch date, there are several issues that he and the organization are experiencing.…

    • 678 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Tamiflu Case

    • 3403 Words
    • 14 Pages

    This expansion in manufacturing capacity has increased production of the drug to over 400 million treatments annually —…

    • 3403 Words
    • 14 Pages
    Powerful Essays
  • Satisfactory Essays

    Case anasysis

    • 300 Words
    • 2 Pages

    FACTS: On April 30, 2010, Barack and George entered into a bet on the outcome of the 2010 Kentucky Derby. On January 28, 2011, Barack, who bet on the winner, wants to collect the $3,000 George had wagered. George paid Barack the $3,000 wager but now wants to recover the funds from Barack.…

    • 300 Words
    • 2 Pages
    Satisfactory Essays
  • Best Essays

    Johnson and Johnson Analysis

    • 3767 Words
    • 14 Pages

    The SWOT Analysis of Johnson and Johnson shows that the company is one of the top players in the industry and has a lot of potential for further growth due to financial strength and experiences .The company sales has increased worldwide allowing for its expansion in more countries and they carry out further research and development on new products. Johnson and Johnson research and development is helping to identify new opportunities which in turns help in complimenting company strength .Several ranges of opportunities are available for the company and the breakthrough in technology and innovations has allowed for new products and services to be available for consumers.…

    • 3767 Words
    • 14 Pages
    Best Essays
  • Good Essays

    In 2006, Peter Vyas, paced his office after a request of 2$ million dollars to relaunch a mini water- oxidation product. Having two failures previously to bring this product to the market the last three years, he had a team who was very confident that this time was the right time. Vyas is the general manager of Filtration unit of Applied Research Technologies, in other words ART. His team had worked on this project and believed that this time they were in the right direction. Because of his recent failures, it also hurt his background. If he supported this he would not only hurt his self again, but his entire team that was behind him.…

    • 840 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Gupta. A. K., & Wilemon. D. L. 1990. Accelerating the development of technology-based new products. California Management Review, 32(2):24-44.…

    • 2167 Words
    • 9 Pages
    Powerful Essays
  • Satisfactory Essays

    Ath Technology

    • 1299 Words
    • 6 Pages

    Scepter pharmaceutical should employ the skilled person in the technology area, especially the founder of ATH technology for future development or control.…

    • 1299 Words
    • 6 Pages
    Satisfactory Essays
  • Powerful Essays

    Biopharma Case Study

    • 1265 Words
    • 6 Pages

    As of 2009, BioPharma is looking to reduce costs across the board. Profits have been steeply declining while production costs are high, especially at its German and Japanese facilities. With exception of India, demand is expected to remain relatively stable for the short-term future, so BioPharma can no longer afford its costly surplus capacity. BioPharma produces and sells two chemicals in bulk. Each plant they currently have is capable of producing both chemicals. They are willing to idle production at the Germany and Japan plants on one or both chemicals in order to reduce costs. They are also willing to reallocate which plant makes how much of each chemical and where they are distributed to.…

    • 1265 Words
    • 6 Pages
    Powerful Essays
  • Good Essays

    In case of this company they have tried to combine the mutually supportive capabilities. They have tried to develop a business model by integrating the drug line and the production capabilities. Furthermore, packaging is arranged as a line hybrid process.…

    • 830 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    REPORT ON BHARTI AIRTEL LIMITED Uploaded for www.projectsparadise.com CONTENTS Acknowledgment 3 Executive Summary 4 Introduction 5 Objectives 8 Methodology 8 • Primary Data Sources • Secondary Data Sources Analysis • SWOT Analysis 12 • BCG Matrix 16 • Porter Model 17 • Ansoff matrix 18 • Environmental Analysis 19 • Competitors Analysis 21 Findings 25 Recommendations 26 Bibliography 27 References…

    • 4719 Words
    • 19 Pages
    Powerful Essays